Back to News
Market Impact: 0.2
Genefluence's rapid, near-patient PCR test for urinary tract infections in first use at the Royal Hospital Chelsea
Source: PR Newswire
Healthcare & BiotechTechnology & InnovationProduct Launches
Genefluence announced the first use of a rapid test designed to identify UTI-causing bacteria and antibiotic-resistance genes at the point of clinical decision-making. The test is intended to help clinicians select an appropriate antibiotic sooner; the article excerpt provides no performance figures or commercial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- What investors need to know about Alphabet's stock-busting earnings report
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- Microsoft’s strong quarter backs up its stock rebound. Here's our new price target
- Google struggling to make AI Mode searches pay
- As Waymo expands overseas, it remains a niche cash-burning business
- Microsoft’s cloud growth accelerates, and so too does the spending